81
Participants
Start Date
November 21, 2016
Primary Completion Date
December 31, 2020
Study Completion Date
December 31, 2020
Temozolomide+Metformin
Low dose temozolomide+metformin for 24 weeks
Temozolomide+Placebo
Low dose temozolomide+placebo for 24 weeks
National Cancer Center Korea, Ilsan
Seoul National University Bundang Hospital, Seongnam-si
Saint Vincent's Hospital, Korea, Suwon
Ajou University Hospital, Suwon
Incheon St. Mary's Hospital, Incheon
Chonnam National University Hwasun Hospital, Hwasun
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Konkuk University Hospital, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Seoul St Mary's Hospital, Seoul
Collaborators (1)
Saint Vincent's Hospital, Korea
OTHER
Incheon St.Mary's Hospital
OTHER
National Cancer Center, Korea
OTHER_GOV
Konkuk University Hospital
OTHER
Seoul National University Bundang Hospital
OTHER
Samsung Medical Center
OTHER
Seoul National University Hospital
OTHER
Asan Medical Center
OTHER
Ajou University School of Medicine
OTHER
Severance Hospital
OTHER
Chonnam National University Hospital
OTHER
Seoul St. Mary's Hospital
OTHER
Yong-Kil Hong
OTHER